about
Cobalamin deficiency, hyperhomocysteinemia, and dementiaAspirin downregulates homocysteine formation in stimulated human peripheral blood mononuclear cellsAnti-inflammatory compound resveratrol suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells in vitroEarly increase of plasma homocysteine in sepsis patients with poor outcomeMacrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.Quantitative profiling of folate and one-carbon metabolism in large-scale epidemiological studies by mass spectrometry.Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients.Homocysteine levels and amyotrophic lateral sclerosis: A possible link.Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.Elevated plasma homocysteine levels in chronic periodontitis: a hospital-based case-control study.Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of ApoAI and IFN-γ in spleen and placenta, and through reduction of methylation potential.The influence of total plasma homocysteine and traditional atherosclerotic risk factors on degree of abdominal aortic aneurysm tissue inflammation.Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder.Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity.Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity.Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases.Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.Impaired Homocysteine Metabolism Associated with High Plasma Interleukin-17A Levels, a Pro-Atherogenic Marker, in an Endogamous Population of North India
P2860
Q24609123-79D9DAA6-61BA-4A88-A2C3-99B984F919A3Q28187537-FCAD9AA9-2973-4183-B415-C123B86AF99FQ28192293-C1D3520B-3111-4F61-8069-6DED5897F834Q34274236-43FA887E-E5F2-485D-B32C-ADFF5CDD2D07Q34486477-CDA7F7DD-C353-4B17-BF3A-32B22CB4E450Q36982670-71CB3BD6-2BDA-4097-84B9-3F868BF06541Q37506250-3C72C88B-1D2C-4C33-986B-C062B6008FF4Q37529527-BDD89212-8F41-4B13-8E34-AE8257ACB122Q38379162-55087EEA-9F16-4401-9417-F67E70152844Q38877141-3BE2FF8C-689F-4957-9000-61FE8F9EE16FQ39839044-6E7E1158-41F4-40F7-8E1A-BACA4B091B79Q43946192-304BF8A1-473D-4004-B155-42F119F102CAQ45916570-53409D33-1D8E-4486-8A6D-D090BF569E9CQ46397604-3AFBF473-DE50-433D-81AA-28C3BB75BB26Q46747918-C7783772-3160-4C2D-9324-D8FD54D6093FQ46762950-E458C7AE-D24F-4B3C-BE8A-64FE11F53922Q47127539-243686B4-DE9D-4F35-AEB6-EA13FB887316Q47865416-59D20897-6176-46CE-AA0A-D248C9190FA3Q48147146-1316B53D-536C-4E5C-B3EB-684E8A217E80Q51745188-D1D379DF-9CC8-4269-8B61-6AA8982BC4CBQ58595471-72B4D0E5-54FE-4E51-9362-DE58DE1E5F8C
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hyperhomocysteinemia and immune activation.
@ast
Hyperhomocysteinemia and immune activation.
@en
type
label
Hyperhomocysteinemia and immune activation.
@ast
Hyperhomocysteinemia and immune activation.
@en
prefLabel
Hyperhomocysteinemia and immune activation.
@ast
Hyperhomocysteinemia and immune activation.
@en
P2093
P2860
P50
P356
P1476
Hyperhomocysteinemia and immune activation.
@en
P2093
Barbara Frick
Barbara Wirleitner
Christiana Winkler
P2860
P304
P356
10.1515/CCLM.2003.221
P577
2003-11-01T00:00:00Z